Joshua Muia

8PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersHaematologyMedical infection agents (incl. prions)Gene and molecular therapyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 01, 2026
The biology and pathophysiology of the proatherogenic metalloprotease ADAMTS7.

Shiwali Goyal, James Muniu, Mohd Akbar Bhat

|Jul 15, 2025
Proof-of-Concept in a Murine Model of Treatment of Thrombotic Thrombocytopenic Purpura Using Engineered Red Blood Cells.

Karl S Roberts, Shouping Zhang, Khulan Batbayar

|Sep 21, 2022
ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation.

Shannen J Deconinck, Christoph Nix, Svenja Barth

|Sep 10, 2021
Plasma and rhADAMTS13 reduce trauma-induced organ failure by restoring the ADAMTS13-VWF axis.

Derek J B Kleinveld, Derek D G Simons, Charlotte Dekimpe

|Jul 24, 2019
Adjuvant low-dose rituximab and plasma exchange for acquired TTP.

Jeffrey I Zwicker, Joshua Muia, Leili Dolatshahi

Pageof 2